Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-14
2011-12-20
Weddington, Kevin E (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C424S776000
Reexamination Certificate
active
08080564
ABSTRACT:
Agents which contains a serotonin derivative as an active ingredient are effective for improving hemodynamics and for preventing or improving deterioration of hemodynamics associated with aging and progression of cardiovascular diseases.
REFERENCES:
patent: 2005/0136137 (2005-06-01), Koyama et al.
patent: 2006/0257540 (2006-11-01), Koyama et al.
patent: 1500499 (2004-06-01), None
patent: 1 132 389 (2001-09-01), None
patent: 1 495 765 (2005-01-01), None
patent: 10-287576 (1998-10-01), None
patent: 2 201 262 (2003-03-01), None
patent: WO 2005/034975 (2005-04-01), None
Yoshihiro Hotta, et al., “Protective effects of antioxidative serotonin derivatives isolated from safflower against postischemic myocardial dysfunction”, Molecular and Cellular Biochemistry, vol. 238, No. 1 & 2, 2002, pp. 151-162.
Kameyama H, et al., Hypertens Res. vol. 28, No. 5 (2005) pp. 439-445.
Extended European Search Report dated Jan. 12, 2011 in European Patent Application No. 06798165.4 filed Sep. 14, 2006.
Moon Kwang-Deog, et al., “Safflower seed extract lowers plasma and hepatic lipids in rats fed high-cholesterol diet”, Nutrition Research 21 (2001) 895-904.
Dermot Kenny, et al., “Effect of Omega-3 Fatty Acids on the Vascular Response to Angiotensin in Normotensive Men”, The American Journal of Cardiology, vol. 70, Nov. 15, 1995, pp. 1347-1352.
Hirofumi Tomiyama, et al., “Non-Invasive Vascular Function Tests: Their Pathophysiological Background and Clinical Application”, Circulation Journal, vol. 74, Jan. 2010, pp. 24-33.
Wendy L. Hall, “Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function”, Nutrition Research Reviews (2009), 22, pp. 18-38.
Hazama Akihiro
Katsuda Shin-ichiro
Koyama Naoto
Suzuki Katsuya
Ajinomoto Co. Inc.
Oblon, Spivak, McClleland, Maier & Neustadt, L.L.P.
Weddington Kevin E
LandOfFree
Hemodynamics improving agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hemodynamics improving agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemodynamics improving agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4258013